The Role of Osteoprotegerin and Its Ligands in Vascular Function
Open Access
- 5 February 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (3), 705
- https://doi.org/10.3390/ijms20030705
Abstract
The superfamily of tumor necrosis factor (TNF) receptors includes osteoprotegerin (OPG) and its ligands, which are receptor activators of nuclear factor kappa-B ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL). The OPG/RANKL/RANK system plays an active role in pathological angiogenesis and inflammation as well as cell survival. It has been demonstrated that there is crosstalk between endothelial cells and osteoblasts during osteogenesis, thus establishing a connection between angiogenesis and osteogenesis. This OPG/RANKL/RANK/TRAIL system acts on specific cell surface receptors, which are then able to transmit their signals to other intracellular components and modify gene expression. Cytokine production and activation of their receptors induce mechanisms to recruit monocytes and neutrophils as well as endothelial cells. Data support the role of an increased OPG/RANKL ratio as a possible marker of progression of endothelial dysfunction in metabolic disorders in relationship with inflammatory marker levels. We review the role of the OPG/RANKL/RANK triad in vascular function as well as molecular mechanisms related to the etiology of vascular diseases. The potential therapeutic strategies may be very promising in the future.Keywords
This publication has 108 references indexed in Scilit:
- The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseasesPharmacology & Therapeutics, 2018
- Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical markerMolecular Medicine Reports, 2017
- Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAILVascular Pharmacology, 2016
- Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding AffinityMolecules and Cells, 2016
- Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearanceInflammation Research, 2016
- Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact CellsPublished by Elsevier BV ,2016
- The beneficial pleiotropic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) within the vasculature: A review of the evidenceAtherosclerosis, 2016
- Tumor Necrosis Factor Related Apoptosis Inducing Ligand (Trail) in Endothelial Response to Biomechanical and Biochemical Stresses in ArteriesJournal of Cellular Biochemistry, 2015
- Biology of the RANKL–RANK–OPG System in Immunity, Bone, and BeyondFrontiers in Immunology, 2014
- Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclastsWorld Journal of Orthopedics, 2012